isoalantolactone has been researched along with Lung Injury, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tian, L; Yang, B; Yuan, CB; Zhou, HY | 1 |
| Ding, YH; He, HQ; Hu, YD; Jiang, HC; Li, XZ; Qian, F; Song, YD; Sun, L; Wu, YX; Yu, KK; Yu, TH; Zhang, DP | 1 |
2 other study(ies) available for isoalantolactone and Lung Injury, Acute
| Article | Year |
|---|---|
Isoalantolactone protects LPS-induced acute lung injury through Nrf2 activation.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Disease Models, Animal; Interleukin-1beta; Lipopolysaccharides; Lung; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; NF-kappa B; Phosphatidylinositol 3-Kinases; Protective Agents; Sesquiterpenes; Signal Transduction; Tumor Necrosis Factor-alpha | 2018 |
Isoalantolactone suppresses LPS-induced inflammation by inhibiting TRAF6 ubiquitination and alleviates acute lung injury.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Cytokines; HEK293 Cells; Humans; Inflammation; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Lung; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B p50 Subunit; Sesquiterpenes; Signal Transduction; TNF Receptor-Associated Factor 6; Ubiquitination | 2019 |